Xueren Feng
Huzhou University(CN)Huzhou Central Hospital(CN)
Publications by Year
Research Areas
Lung Cancer Research Studies, Lung Cancer Treatments and Mutations, MicroRNA in disease regulation, Chronic Obstructive Pulmonary Disease (COPD) Research, Cancer-related molecular mechanisms research
Most-Cited Works
- → circRNAs and Exosomes: A Mysterious Frontier for Human Cancer(2019)142 cited
- → Long noncoding RNA PCAT6 functions as an oncogene by binding to EZH2 and suppressing LATS2 in non-small-cell lung cancer(2018)110 cited
- → Serum microRNA 125b as a diagnostic or prognostic biomarker for advanced NSCLC patients receiving cisplatin-based chemotherapy(2012)97 cited
- → RAGE Genetic Polymorphisms Are Associated with Risk, Chemotherapy Response and Prognosis in Patients with Advanced NSCLC(2012)38 cited
- → Clostridium difficile carriage in hospitalized cancer patients: a prospective investigation in eastern China(2014)28 cited
- → The role of adiponectin (ADIPOQ) gene polymorphisms in the susceptibility and prognosis of non-small cell lung cancer(2011)26 cited
- → <p>Radiofrequency Ablation with Continued EGFR Tyrosine Kinase Inhibitor Therapy Prolongs Disease Control in EGFR-Mutant Advanced Lung Cancers with Acquired Resistance to EGFR Tyrosine Kinase Inhibitors: Two Case Reports</p>(2020)3 cited
- → Facile Preparation of Paclitaxel Nano-Suspensions to Treat Lung Cancer(2022)2 cited
- → Osimertinib for an Advanced NSCLC Patient with Two Common EGFR Mutations and a Concomitant MET Exon 14 Skipping Mutation: A Case Report(2023)2 cited
- → Case Report: Heterogeneity of Resistance Mechanisms in Different Lesions Co-Mediate Acquired Resistance to First-Line Icotinib in EGFR Mutant Non-Small Cell Lung Cancer(2022)2 cited